A visionary in drug development, Jeff Geschwind, MD, founded Cage Pharma. His work focuses on creating novel cancer drugs that target tumor metabolism, attacking the very energy source cancers need to grow. https://medicine.yale.edu/news/medicineatyale/article/two-clinical-leaders-join-medical-school-as-administrators/